Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Oramed Pharmaceuticals (ORMP) - Cash on Hand
Cash on Hand as of December 2023 : $0.16 B
According to Oramed Pharmaceuticals's latest financial reports the company has $0.16 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Oramed Pharmaceuticals - Cash on Hand chart (from 2006 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | 4.06% |
| 2022-12-31 | $0.15 B | |
| 2021-08-31 | $94.14 M | 135.94% |
| 2020-08-31 | $39.9 M | 23.6% |
| 2019-08-31 | $32.28 M | 5.97% |
| 2018-08-31 | $30.46 M | 51.39% |
| 2017-08-31 | $20.12 M | -35.12% |
| 2016-08-31 | $31.01 M | 80.02% |
| 2015-08-31 | $17.22 M | -19.07% |
| 2014-08-31 | $21.29 M | 151.21% |
| 2013-08-31 | $8.47 M | 66.65% |
| 2012-08-31 | $5.08 M | 167.95% |
| 2011-08-31 | $1.89 M | 58.21% |
| 2010-08-31 | $1.19 M | -55.84% |
| 2009-08-31 | $2.71 M | -45.61% |
| 2008-08-31 | $4.99 M | 160.44% |
| 2007-08-31 | $1.91 M | 988.6% |
| 2006-08-31 | $0.17 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $1.34 B | 730.78% | 🇩🇰 Denmark |
 Sanofi SNY | $9.92 B | 6,026.70% | 🇫🇷 France |
 Ultragenyx RARE | $0.57 B | 256.20% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.17 B | 4.92% | 🇺🇸 USA |
 Compugen CGEN | $50.68 M | -68.72% | 🇮🇱 Israel |